Vicinium

BIOLOGICAL2 trials

Sponsors

Sesen Bio, Inc.

Conditions

Bladder CancerBladder NeoplasmsBladder TumorsUrinary Bladder Cancer

Phase 2

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

CompletedNCT00462488

Sesen Bio, Inc.Bladder Cancer, Bladder Neoplasms, Bladder Tumors +1

Start: 2007-03-31End: 2009-10-31Updated: 2020-05-12

Phase 3

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

CompletedNCT02449239

Sesen Bio, Inc.Bladder Cancer

Start: 2015-08-31End: 2022-05-31Updated: 2023-07-24

Related Papers

PD03-02 PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER

The Journal of Urology2020-04-0131 citations

Antibodies to watch in 2020.

2020-01-01328 citations

LBA27 PHASE 3 STUDY OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: INITIAL RESULTS

The Journal of Urology2018-04-0117 citations